Cargando…
Knockdown of PKM2 suppresses tumor progression in human cervical cancer by modulating epithelial–mesenchymal transition via Wnt/β-catenin signaling
BACKGROUND: Pyruvate kinase isozyme type M2 (PKM2) is a key glycolytic enzyme and is upregulated in multiple human malignancies. However, the role of PKM2 in human cervical cancer (CC) remains elusive. Thus, this study explored the role of PKM2 in CC by detecting its expression patterns in human CC...
Autores principales: | Lin, Yanzhu, Meng, Fanqing, Lu, Zhiyuan, Chen, Kai, Tao, Yalan, Ouyang, Yi, Cao, Xinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177516/ https://www.ncbi.nlm.nih.gov/pubmed/30323675 http://dx.doi.org/10.2147/CMAR.S178219 |
Ejemplares similares
-
Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells
por: Lin, Yanzhu, et al.
Publicado: (2019) -
Knockdown of IQGAP1 inhibits proliferation and epithelial–mesenchymal transition by Wnt/β-catenin pathway in thyroid cancer
por: Su, Dongyue, et al.
Publicado: (2017) -
Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis
por: Lin, Yanzhu, et al.
Publicado: (2018) -
Knockdown of CD146 promotes endothelial-to-mesenchymal transition via Wnt/β-catenin pathway
por: Zhang, Zhao-Yu, et al.
Publicado: (2022) -
WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition
por: Zhou, Yun, et al.
Publicado: (2016)